Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gallus

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Internal Medicine Journal|May 13, 2014
Low-molecular-weight heparin biosimilars: potential implications for clinical practice. Australian Low-Molecular-Weight Heparin Biosimilar Working Group (ALBW)H Nandurkar, B Chong, H Salem, et al.
Pharmacology, Biochemistry, and Behavior|September 1, 1982
Environmental determinants of parachloroamphetamine toxicity in ratsJ A Gallus, R G Sewell, N I Nearchou, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 1982
p-Chlorophenylalanine effects on shock-induced attack and pressing responses in ratsR G Sewell, J A Gallus, F P Gault, et al.
Journal of Thrombosis and Haemostasis : JTH|September 18, 2007
The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacementM R Lassen, B L Davidson, A Gallus, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 1983
Tripelennamine effects on body and organ weights, water intake, and several behaviors of ratsK P Nanry, R G Sewell, J A Gallus, et al.
Thrombosis Research|October 15, 1989
The influence of Org 10172, an antithrombotic heparinoid, on urinary blood loss after transurethral prostatectomyA Gallus, W Murphy, J Nacey, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1983
Parachloroamphetamine toxicity in mice: influence of body weight, sex and doseJ W Kesselring, R G Sewell, J A Gallus, et al.
Canadian Medical Association Journal|June 19, 1976
Thrombotic thrombocytopenic purpura: a syndrome of intravascular platelet consumptionP B Neame, J Hirsh, G Browman, et al.
Thrombosis and Haemostasis|October 18, 1993
Orgaran (Org 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease? A double-blind, randomised, multicentre comparison. ANZ-Organon Investigators' GroupA Gallus, J Cade, P Ockelford, et al.
Journal of Thrombosis and Haemostasis : JTH|April 4, 2007
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trialsB L Davidson, H R Büller, H Decousus, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Internal Medicine Journal|May 13, 2014
Low-molecular-weight heparin biosimilars: potential implications for clinical practice. Australian Low-Molecular-Weight Heparin Biosimilar Working Group (ALBW)H Nandurkar, B Chong, H Salem, et al.
Pharmacology, Biochemistry, and Behavior|September 1, 1982
Environmental determinants of parachloroamphetamine toxicity in ratsJ A Gallus, R G Sewell, N I Nearchou, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 1982
p-Chlorophenylalanine effects on shock-induced attack and pressing responses in ratsR G Sewell, J A Gallus, F P Gault, et al.
Journal of Thrombosis and Haemostasis : JTH|September 18, 2007
The efficacy and safety of apixaban, an oral, direct factor Xa inhibitor, as thromboprophylaxis in patients following total knee replacementM R Lassen, B L Davidson, A Gallus, et al.
Pharmacology, Biochemistry, and Behavior|November 1, 1983
Tripelennamine effects on body and organ weights, water intake, and several behaviors of ratsK P Nanry, R G Sewell, J A Gallus, et al.
Thrombosis Research|October 15, 1989
The influence of Org 10172, an antithrombotic heparinoid, on urinary blood loss after transurethral prostatectomyA Gallus, W Murphy, J Nacey, et al.
Pharmacology, Biochemistry, and Behavior|May 1, 1983
Parachloroamphetamine toxicity in mice: influence of body weight, sex and doseJ W Kesselring, R G Sewell, J A Gallus, et al.
Canadian Medical Association Journal|June 19, 1976
Thrombotic thrombocytopenic purpura: a syndrome of intravascular platelet consumptionP B Neame, J Hirsh, G Browman, et al.
Thrombosis and Haemostasis|October 18, 1993
Orgaran (Org 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease? A double-blind, randomised, multicentre comparison. ANZ-Organon Investigators' GroupA Gallus, J Cade, P Ockelford, et al.
Journal of Thrombosis and Haemostasis : JTH|April 4, 2007
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trialsB L Davidson, H R Büller, H Decousus, et al.
Pageof 3